Advertisement

Mycopathologia

, Volume 176, Issue 1–2, pp 107–111 | Cite as

Non-Healing Ulcer Due to Trichosporon loubieri in an Immunocompetent Host and Review of Published Reports

  • Vijaylatha Rastogi
  • Shivaprakash M. Rudramurthy
  • Madhu Maheshwari
  • P. S. Nirwan
  • Arunaloke Chakrabarti
  • Shivra Batra
Article

Abstract

We report here a case of non-healing ulcer due to Trichosporon loubieri in an apparently immunocompetent female. The identity of isolate was confirmed by DNA sequencing of D1/D2 region of 26S rDNA. The minimum inhibitory concentrations of the isolate were amphotericin B—0.5 μg/ml; fluconazole—4 μg/ml; posaconazole—0.25 μg/ml; voriconazole—0.06 μg/ml. The patient was managed by extensive debridement and oral fluconazole 150 mg daily for 6 weeks. She responded to therapy. To the best of our knowledge, till date, this is the fourth report of human infection due to T. loubieri and the first of its kind in an immunocompetent host. A review of published literature on infections due to T. loubieri is also included.

Keywords

Trichosporon loubieri Non-healing ulcer Immunocompetent host 

References

  1. 1.
    Gueho E, Improvisi L, de hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses. 1994;37:3–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Sugita T, Nishikawa A, Ikeda R, Shinoda T. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J Clin Microbiol. 1999;37:1985–93.PubMedGoogle Scholar
  3. 3.
    Fell JW, Scorzetti G. Reassignment of the basidiomycetous yeasts Trichosporon pullulans to Guehomyces pullulans gen.nov. comb. nov. and Hyalodendron lignicola to Trichosporon lignicola.comb. nov. Int J Syst Evol Microbiol. 2004;54:995–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Middelhoven WJ, Scorzetti G, Fell JW. Systematics of the anamorphic basidiomycetous yeast genus Trichosporon behrend with the description of five novel species: Trichosporon vadense, T. smithiae, T. dehoogii, T. scarabaeorum and T. gamsii. Int J Syst Evol Microbiol. 2004;54:975–86.PubMedCrossRefGoogle Scholar
  5. 5.
    Pagnocca FC, Legaspe MFC, Rodrigues A, Ruivo CCC, Nagamoto NS, Bacci M, Forti LC. Yeasts isolated from a fungus-growing ant nest, including the description of Trichosporon chiarellii sp. nov., an anamorphic basidiomycetous yeast. Int J Syst Evol Microbiol. 2010;60:1454–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Colombo AL, Carolina A, Padovan B, Guilherme MC. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev. 2011;24:682–700.PubMedCrossRefGoogle Scholar
  7. 7.
    Padhye AA, Verghese S, Ravichandran P, Balamurugan G, Hall L, Padmaja P, Fernandez MC. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol. 2003;41:479–82.PubMedCrossRefGoogle Scholar
  8. 8.
    CLSI. M27–A3. Reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed. Wayne: Clinical and Laboratory Standards Institute; 2008.Google Scholar
  9. 9.
    Wolf DG, Falk R, Hacham M, Theelen B, Boekhout T, Scorzetty G, Shapiro M, Block C, Salkin IF, Polacheck I. Multidrug resistant Trichosporon asahii infection of non-granulocytopenic patients in three intensive care units. J Clin Microbiol. 2001;39:4420–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Gueho E, Smith MT, de Hoog GS, Billon-Grand G, Christen R, Batenburg van de Vegte WH. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek. 1992;61:289–316.PubMedCrossRefGoogle Scholar
  11. 11.
    de hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of clinical fungi. Utrecht: Centraalbureau voor Schimmelcultures; 2000.Google Scholar
  12. 12.
    Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am. 2002;16:915–33.PubMedCrossRefGoogle Scholar
  13. 13.
    Barnett JA, Payne RW, Yarrow D. Yeast characteristics and identification. 3rd ed. Cambridge: Cambridge University Press; 2000.Google Scholar
  14. 14.
    Marty FM, Barouch DH, Coakley EP, Baden LR. Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol. 2003;41:5317–20.PubMedCrossRefGoogle Scholar
  15. 15.
    Nishiura Y, Nakagawa YK, Suga M, Shinoda T, Gueho E, Ando M. Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J Med Vet Mycol. 1997;35:45–52.PubMedCrossRefGoogle Scholar
  16. 16.
    Sugita T, Ikeda R, Nishikawa A. Analysis of Trichosporon isolates obtained from the houses of patients with summer type hypersensitivity pneumonitis. J Clin Microbiol. 2004;42:5467–71.PubMedCrossRefGoogle Scholar
  17. 17.
    Sharman MJ, Stayt J, McGill SE, Mansfield CS. Clinical resolution of a nasal granuloma caused by Trichosporon loubieri. J Feline Med Surg. 2010;12:345–50.PubMedCrossRefGoogle Scholar
  18. 18.
    Gabriel F, Noel T, Accoceberry I. Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma. Med Mycol. 2011;49:306–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Harupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis. 1983;147:199–203.CrossRefGoogle Scholar
  20. 20.
    Anaissie E, Gokaslan A, Hachem R, Rubin R, Griffin G, Robinson R, Sobel J, Bodey G. Azole therapy for trichosporonosis. Clinical evaluation of eight patients, experimental therapy for murine infection and review. Clin Infect Dis. 1992;15:781–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, Goto T, Tomishima M, Okhi H, Yamada A, Kawabata K, Takasugi H, Sakane K, Tanaka H, Matsumo F, Kubahara S. In vitro activities of a new lipopeptide antifungal agent, FK 463, against a variety of clinically important fungi. Antimicrob Agents Chemother. 2000;44:57–62.PubMedCrossRefGoogle Scholar
  22. 22.
    Uzun O, Kocagoz S, Centikaya Y, Arikan S, Unal S. In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B, and fluconazole against clinical yeast isolates. Antimicrob Agents Chemother. 1997;41:1156–7.PubMedGoogle Scholar
  23. 23.
    Girmenia C, Pagano L, Martino B, Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with haematological malignancies: a retrospective multicentre study from Italy and review of the literature. J Clin Microbiol. 2005;43:1818–28.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Vijaylatha Rastogi
    • 1
  • Shivaprakash M. Rudramurthy
    • 2
  • Madhu Maheshwari
    • 3
  • P. S. Nirwan
    • 1
  • Arunaloke Chakrabarti
    • 2
  • Shivra Batra
    • 1
  1. 1.Department of MicrobiologyJLN Medical College and Associated HospitalsAjmerIndia
  2. 2.Department of Medical MicrobiologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia
  3. 3.Department of Plastic SurgeryJLN Medical College and Associated HospitalsAjmerIndia

Personalised recommendations